UpdatesPress Release

Caplin Point's subsidiary, Caplin Steriles, gained USFDA approval for Sodium Phosphates Injection.

Caplin Point Laboratories Limited logo
Caplin Point Laboratories LimitedCAPLIPOINT · Filed with the exchange

This generic drug competes in a US market with annual sales of approximately US$67 million, strengthening its regulated market footprint.

Read the original filing(PDF)

No comments yet. Be the first.

More from Caplin Point Laboratories Limited

All announcements